Effects of oxygen therapy on systemic inflammation and myeloperoxidase modified LDL in hypoxemic COPD patients.
Zouaoui Boudjeltia
K
K
Tragas
G
G
Babar
S
S
Moscariello
A
A
Nuyens
V
V
Van Antwerpen
P
P
Gilbert
O
O
Ducobu
J
J
Brohee
D
D
Vanhaeverbeek
M
M
Van Meerhaeghe
A
A
D008078:Cholesterol, LDL / Q000378:metabolism*; D006801:Humans; D007249:Inflammation / Q000628:therapy*; D016209:Interleukin-8 / Q000097:blood; D018384:Oxidative Stress; D010100:Oxygen / Q000378:metabolism*; D010102:Oxygen Inhalation Therapy / Q000379:methods*; D009195:Peroxidase / Q000378:metabolism*; D029424:Pulmonary Disease, Chronic Obstructive / Q000097:blood* / Q000628:therapy*; D016212:Transforming Growth Factor beta / Q000097:blood; D016896:Treatment Outcome
D008078:Cholesterol, LDL; D016209:Interleukin-8; D016212:Transforming Growth Factor beta; D009195:Peroxidase; D010100:Oxygen